Psychosis reflects accelerated or dysregulated aging across multiple physiological systems rather than a localized brain disorder, with implications for how psychiatric conditions are understood and treated as systemic dysfunction. This reframing suggests that interventions targeting underlying aging mechanisms may address psychotic symptoms more effectively than approaches focused on single neurochemical pathways.
Key Points
- Psychosis involves coordinated dysfunction across multiple organ systems, not isolated brain patholo
- Accelerated aging mechanisms appear central to psychotic disease development and progression.
- System-level interventions may be more effective than single-target psychiatric pharmacology.
Longevity Analysis
Viewing psychosis as aberrant aging fundamentally shifts how we approach both prevention and treatment. Rather than targeting dopamine in isolation, this perspective demands attention to the interconnected failure of systems that support cognitive resilience—including how the body defends itself, produces energy, manages stress response, and regenerates neural tissue. The recognition that psychotic symptoms emerge from systemic dysregulation suggests that optimizing foundational physiological processes—reducing inflammatory and metabolic stressors, restoring proper nervous system signaling, supporting cellular repair mechanisms—may reverse or prevent the cognitive decline that characterizes psychotic illness. For practitioners, this inverts the conventional diagnostic hierarchy: understanding what interferes with normal aging processes becomes as important as naming the psychiatric syndrome.
Original published by Nature - npj Aging, by Rachel Upthegrove.

